Goldman Sachs’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.7M | Buy |
98,348
+12,567
| +15% | +$1.93M | ﹤0.01% | 2674 |
|
|
2025
Q4 | $11.8M | Buy |
85,781
+26,020
| +44% | +$3.36M | ﹤0.01% | 2943 |
|
|
2025
Q3 | $7.26M | Buy |
59,761
+11,898
| +25% | +$1.28M | ﹤0.01% | 3291 |
|
|
2025
Q2 | $5.12M | Sell |
47,863
-25,909
| -35% | -$2.59M | ﹤0.01% | 3384 |
|
|
2025
Q1 | $6.85M | Buy |
73,772
+4,879
| +7% | +$473K | ﹤0.01% | 3038 |
|
|
2024
Q4 | $7.41M | Sell |
68,893
-15,664
| -19% | -$1.91M | ﹤0.01% | 3068 |
|
|
2024
Q3 | $10.6M | Buy |
84,557
+28,011
| +50% | +$3.52M | ﹤0.01% | 2646 |
|
|
2024
Q2 | $6.13M | Buy |
56,546
+6,547
| +13% | +$638K | ﹤0.01% | 2971 |
|
|
2024
Q1 | $4.73M | Sell |
49,999
-27,581
| -36% | -$2.61M | ﹤0.01% | 3140 |
|
|
2023
Q4 | $7.17M | Sell |
77,580
-131,918
| -63% | -$10.1M | ﹤0.01% | 2823 |
|
|
2023
Q3 | $13.4M | Buy |
209,498
+6,952
| +3% | +$445K | ﹤0.01% | 2140 |
|
|
2023
Q2 | $12.5M | Buy |
202,546
+37,438
| +23% | +$2.22M | ﹤0.01% | 2239 |
|
|
2023
Q1 | $9.59M | Buy |
165,108
+23,196
| +16% | +$1.33M | ﹤0.01% | 2461 |
|
|
2022
Q4 | $8.44M | Buy |
141,912
+45,472
| +47% | +$2.76M | ﹤0.01% | 2723 |
|
|
2022
Q3 | $6.11M | Buy |
96,440
+14,381
| +18% | +$999K | ﹤0.01% | 2962 |
|
|
2022
Q2 | $5.74M | Buy |
82,059
+13,521
| +20% | +$947K | ﹤0.01% | 3004 |
|
|
2022
Q1 | $4.81M | Sell |
68,538
-997
| -1% | -$67.1K | ﹤0.01% | 3386 |
|
|
2021
Q4 | $4.72M | Sell |
69,535
-20,019
| -22% | -$1.39M | ﹤0.01% | 3467 |
|
|
2021
Q3 | $6.27M | Sell |
89,554
-20,946
| -19% | -$1.52M | ﹤0.01% | 3159 |
|
|
2021
Q2 | $7.72M | Buy |
110,500
+56,031
| +103% | +$4.07M | ﹤0.01% | 2944 |
|
|
2021
Q1 | $4.24M | Buy |
54,469
+2,094
| +4% | +$148K | ﹤0.01% | 3287 |
|
|
2020
Q4 | $3.48M | Buy |
52,375
+3,021
| +6% | +$199K | ﹤0.01% | 3292 |
|
|
2020
Q3 | $3.08M | Buy |
49,354
+22,314
| +83% | +$1.4M | ﹤0.01% | 3266 |
|
|
2020
Q2 | $1.72M | Buy |
27,040
+54
| +0.2% | +$3.62K | ﹤0.01% | 3569 |
|
|
2020
Q1 | $1.94M | Buy |
26,986
+1,032
| +4% | +$81.6K | ﹤0.01% | 3332 |
|
|
2019
Q4 | $2.24M | Sell |
25,954
-284
| -1% | -$23.7K | ﹤0.01% | 3568 |
|
|
2019
Q3 | $2.15M | Buy |
26,238
+15,514
| +145% | +$1.28M | ﹤0.01% | 3479 |
|
|
2019
Q2 | $870K | Buy |
10,724
+1,789
| +20% | +$138K | ﹤0.01% | 4077 |
|
|
2019
Q1 | $678K | Sell |
8,935
-42,626
| -83% | -$3.38M | ﹤0.01% | 4268 |
|
|
2018
Q4 | $4.04M | Buy |
51,561
+13,049
| +34% | +$1.02M | ﹤0.01% | 3057 |
|
|
2018
Q3 | $2.9M | Buy |
38,512
+621
| +2% | +$45.7K | ﹤0.01% | 3344 |
|
|
2018
Q2 | $2.67M | Sell |
37,891
-11,446
| -23% | -$749K | ﹤0.01% | 3425 |
|
|
2018
Q1 | $2.94M | Buy |
49,337
+11,749
| +31% | +$720K | ﹤0.01% | 3305 |
|
|
2017
Q4 | $2.29M | Sell |
37,588
-566
| -1% | -$36.1K | ﹤0.01% | 3670 |
|
|
2017
Q3 | $2.39M | Buy |
38,154
+22,476
| +143% | +$1.45M | ﹤0.01% | 3820 |
|
|
2017
Q2 | $1.1M | Buy |
15,678
+5,186
| +49% | +$370K | ﹤0.01% | 4369 |
|
|
2017
Q1 | $748K | Buy |
10,492
+3,080
| +42% | +$228K | ﹤0.01% | 4649 |
|
|
2016
Q4 | $562K | Sell |
7,412
-7,996
| -52% | -$554K | ﹤0.01% | 4954 |
|
|
2016
Q3 | $1.02M | Buy |
15,408
+5,562
| +56% | +$361K | ﹤0.01% | 4386 |
|
|
2016
Q2 | $637K | Buy |
9,846
+4,016
| +69% | +$255K | ﹤0.01% | 4617 |
|
|
2016
Q1 | $363K | Buy |
5,830
+1,616
| +38% | +$101K | ﹤0.01% | 5072 |
|
|
2015
Q4 | $260K | Buy |
+4,214
| New | +$273K | ﹤0.01% | 5479 |
|
|
2014
Q4 | – | Sell |
-4,636
| Closed | -$257K | – | 7248 |
|
|
2014
Q3 | $257K | Sell |
4,636
-8,180
| -64% | -$462K | ﹤0.01% | 5913 |
|
|
2014
Q2 | $721K | Sell |
12,816
-2,900
| -18% | -$158K | ﹤0.01% | 5012 |
|
|
2014
Q1 | $876K | Sell |
15,716
-13,050
| -45% | -$684K | ﹤0.01% | 4809 |
|
|
2013
Q4 | $1.55M | Sell |
28,766
-697
| -2% | -$35.6K | ﹤0.01% | 4332 |
|
|
2013
Q3 | $1.39M | Buy |
29,463
+12,626
| +75% | +$603K | ﹤0.01% | 4281 |
|
|
2013
Q2 | $805K | Buy |
+16,837
| New | +$786K | ﹤0.01% | 4567 |
|
Other funds holding NHC
MSIIA
VPM
VCM
MHS
Goldman Sachs's NHC Position: Q1 2026 in Review
Goldman Sachs increased its National Healthcare (NHC) stake by 15% in Q1 2026, buying an estimated $1.93M and bringing the position to 98,348 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2674.
Goldman Sachs first reported a position in NHC in Q2 2013 and has held it in 48 quarters since. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.
- Goldman Sachs held 98,348 shares of National Healthcare worth $15.7M as of Q1 2026.
- Goldman Sachs bought 12,567 National Healthcare shares in Q1 2026, an estimated $1.93M.
- National Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2674 holding.
- Goldman Sachs first reported a position in National Healthcare in Q2 2013 and has held it in 48 quarters since.
- 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.